Men's Health Supplements: Evidence vs Marketing

The men's health supplement industry has perfected a marketing formula. Browse any supplement aisle and you'll see bottles promising to "boost testosterone naturally," "reclaim your alpha male status," and "support male vitality." The market has grown to $75 billion in 2024, projected to reach $132 billion by 2030.

Most of it doesn't work.

This is a $3.7 billion global segment, expected to reach nearly $11 billion by 2035. Millions of men are spending money on products that range from ineffective to potentially contaminated with undeclared pharmaceutical ingredients.

Let's examine what the evidence actually says about the most popular men's health supplements: what works, what doesn't, and what men actually need versus what's marketed to them.

The testosterone booster market has grown explosively. The fastest-growing segment is men aged 25-45 influenced by fitness and bodybuilding culture. Direct-to-consumer brands are growing through subscription models, and consumers are increasingly demanding transparency through third-party testing and detailed ingredient sourcing.

Here's the problem: most testosterone boosters don't meaningfully raise testosterone in healthy men with normal baseline levels.

The ingredients with the strongest evidence (zinc, ashwagandha, tongkat ali) work through specific mechanisms that don't apply to everyone. Zinc only works if you're deficient. Ashwagandha works by reducing cortisol. Tongkat ali shows promise primarily in aging men with low baseline testosterone.

Healthy men with adequate nutrition and normal stress levels will see minimal to no benefit from most testosterone booster formulations. Yet the marketing continues to target exactly this demographic with promises that can't be substantiated.

D-aspartic acid became a supplement industry darling based on one early study. In that trial, 20 out of 23 healthy men aged 27-37 who took 3.12 grams of D-aspartic acid daily had higher testosterone levels at the end of a 12-day study. Average increase: 42% during supplementation. Three days after stopping, testosterone levels were still 22% higher.

That's an extraordinary result. It caught the attention of supplement manufacturers, who began incorporating D-aspartic acid into countless formulations.

Follow-up studies told a different story.

A systematic review found that while D-aspartic acid enhances testosterone in animal studies, studies in humans yielded inconsistent results. Research in resistance-trained men demonstrated no changes and, in some cases, reductions in testosterone levels.

One study using a 6-gram dose found that total testosterone was significantly reduced. Free testosterone showed the 6-gram dose was significantly reduced compared to placebo. Males involved in resistance training taking six grams of D-aspartic acid per day for 14 days showed testosterone levels actually decreased.

The transient rise seen in the first week is lost by week four. D-aspartic acid may work briefly in untrained, sedentary men but fails in athletes and trained individuals (the exact demographic targeted by these supplements).

This is a textbook case of publication bias and replication failure. One positive study creates market momentum. Negative follow-up studies get published in specialized journals and ignored by marketing departments. Years later, D-aspartic acid remains a staple ingredient despite the weight of evidence showing it doesn't work as advertised.

Tribulus terrestris has an even weaker evidence base. Analysis of clinical trials found that 8 out of 10 studies did not report significant changes in androgen profile following tribulus terrestris supplementation. Only two studies showed significant increases in total testosterone levels, and these had low clinical magnitude (60-70 ng/dL) and involved subjects with hypogonadism.

Meta-analyses showed tribulus terrestris resulted in nonsignificant increases in testosterone and luteinizing hormone. The current scientific consensus: evidence to date suggests tribulus terrestris is ineffective for increasing testosterone levels in humans.

Tribulus terrestris does show some benefits for erectile dysfunction and fertility that have nothing to do with testosterone. Supplementation at doses of 400-750 mg per day for 1-3 months improved erectile dysfunction in 3 of 5 studies. Meta-analyses involving 133 subjects showed significant improvements in sperm concentration and sperm motility.

These are legitimate benefits. But they're not testosterone enhancement, which is how tribulus is marketed in the vast majority of formulations. Clinical trials report mixed results for erectile dysfunction, and marketing claims regarding testosterone are unsubstantiated.

Fenugreek represents a more nuanced case. Unlike D-aspartic acid and tribulus, fenugreek actually has a plausible mechanism of action supported by multiple studies.

Fenugreek may be an incomplete 5-alpha reductase and aromatase inhibitor. It works by inhibiting enzymes that naturally break down testosterone, allowing more testosterone to remain in circulation. The androgenic activity is likely due to soluble steroidal saponins, specifically furostanol glycosides that complex cholesterol in cell membranes.

Clinical trials support this mechanism. A double-blind, randomized, placebo-controlled trial of 120 healthy men aged 43-70 receiving 600 mg per day for 12 weeks showed positive effects. Another study with 95 men aged 40-80 completed a 12-week intervention with doses of 600 mg, 1200 mg, and 1800 mg of fenugreek extract. Meta-analysis found that fenugreek extract has a significant effect on total serum testosterone.

The standardized extract Testofen has been specifically studied, establishing 250-600 mg of fenugreek seed extract daily as the therapeutic range over 8-12 weeks.

The verdict: fenugreek has modest evidence for testosterone support, likely through enzyme inhibition rather than direct hormonal stimulation. Effects are small and primarily seen in free testosterone rather than total testosterone. Unlike D-aspartic acid and tribulus, it's not entirely without merit.

Tongkat ali, specifically the standardized Physta extract, stands out as one of the few supplements with actual testosterone-raising evidence supported by multiple well-designed trials.

The clinical evidence centers on Physta at 200 mg daily. In one trial, subjects given 100 mg, 200 mg, or placebo daily for 12 weeks showed that the 200 mg dose increased serum total testosterone within two weeks. Significant increases in total testosterone levels were observed at weeks 4, 8, and 12 compared to placebo. The 200 mg dose improved total testosterone levels, reduced aging symptoms, and reduced fatigue as early as two weeks of supplementation. 200 mg (but not 100 mg) increased muscle strength significantly at week 12.

Additional research showed tongkat ali produced approximately 10-15% serum testosterone increase after 2 weeks at 600 mg per day, and approximately 20% serum testosterone increase after 90 days at 250 mg twice daily in healthy middle-aged men.

This is one of the few supplements with actual testosterone-raising evidence in aging men with baseline low testosterone. The mechanism appears to work through supporting natural production pathways rather than pharmacologically elevating testosterone, and the effect is most pronounced in men whose testosterone has declined with age.

Zinc's relationship to testosterone is well-established but frequently misunderstood. The foundational study by Prasad et al. in 1996 examined 40 normal men aged 20-80 years and found that serum testosterone concentrations significantly correlated with cellular zinc concentrations. Specifically, lymphocyte zinc correlated with serum testosterone (r = 0.43, p = 0.006) and granulocyte zinc correlated with testosterone (r = 0.30, p = 0.03).

The study demonstrated dramatic effects in two populations. In young men, dietary zinc restriction caused a significant decrease in serum testosterone after 20 weeks. Testosterone levels dropped from 39.9 ± 7.1 to 10.6 ± 3.6 nmol/L (approximately a 75% decline). In elderly men, zinc supplementation in marginally zinc-deficient subjects for six months resulted in testosterone increase from 8.3 ± 6.3 to 16.0 ± 4.4 nmol/L, nearly doubling testosterone levels.

The critical insight: zinc only works if deficient. Supplementation restores testosterone in deficient men but doesn't raise levels above baseline in replete men.

Analysis from NHANES 2017-March 2020 found average dietary zinc intake of 339 mg per day for men ages 19 and older. While specific zinc deficiency prevalence data is limited, the dramatic response to zinc in Prasad's studies suggests marginal zinc deficiency may be common, particularly in elderly men.

Form matters for zinc supplementation. Comparative studies found that median fractional absorption of zinc citrate (61.3%) and zinc gluconate (60.9%) was significantly higher than zinc oxide (49.9%). Three participants in one study had little or no absorption from zinc oxide. The recommendation: zinc glycinate and zinc gluconate are better absorbed than other forms. Dosing for testosterone support is 15-30 mg supplementation to restore testosterone in deficient men. Higher doses don't provide additional benefit in replete individuals.

Ashwagandha is one of the few supplements with actual testosterone-raising evidence in men, working through stress and cortisol reduction rather than direct hormonal stimulation.

A double-blind, randomized, placebo-controlled, crossover study in aging, overweight males (Lopresti et al., 2019) found that ashwagandha supplementation over 8 weeks was associated with 15% higher levels of salivary testosterone compared to placebo and 18% higher levels of DHEA-S compared to placebo.

The 18% increase in DHEA-S is particularly significant because DHEA (dehydroepiandrosterone) is a precursor hormone to testosterone. DHEA-S levels naturally decline with age, and elevated DHEA-S may support testosterone synthesis pathways.

Another study (Wankhede et al., 2015) examined ashwagandha root extract at 600 mg per day in men undergoing resistance training and found it significantly improved free testosterone and total testosterone levels while also demonstrating benefits for muscle strength.

A multi-continent study with 1000 participants confirmed that 600 mg daily significantly reduced stress, anxiety, and serum cortisol. A separate 24-week study showed 600 mg reduced stress scores, food cravings, and cortisol levels.

The mechanism works through cortisol reduction. Studies with both 250 mg per day and 600 mg per day significantly reduced stress, anxiety, and serum cortisol levels compared to placebo, with the 600 mg per day dose being more efficacious. A 2023 systematic review of 9 studies found ashwagandha supplements for 30-112 days were associated with reduced cortisol secretion by 11-32.63%.

High cortisol levels can suppress testosterone production. By reducing cortisol, KSM-66 allows the hypothalamic-pituitary-gonadal axis to function optimally, supporting natural luteinizing hormone release. The withanolides in ashwagandha suppress corticotropin-releasing hormone production, enhance glucocorticoid sensitivity, restore HPA feedback loops, and can directly interact with glucocorticoid receptors in the brain. GABAergic activity and positive impact on sleep quality reduce stress.

Ashwagandha at 600 mg per day significantly improved sleep actigraphy parameters including sleep onset latency, total sleep time, wake after sleep onset, and sleep efficiency. The sleep improvement creates a permissive environment for testosterone production, as testosterone is primarily produced during deep sleep.

Safety data from a 12-month study of KSM-66 at 600 mg per day showed no deleterious effects on hepatic, renal, and thyroid function parameters.

Ashwagandha, specifically KSM-66 standardized extract, is one of the strongest evidence-backed supplements for men's hormonal health. Unlike most "testosterone boosters," it works through a legitimate physiological mechanism. Effective dose: 600 mg per day for 8-12 weeks.

Saw palmetto remains one of the most widely recommended supplements for prostate health, particularly for benign prostatic hyperplasia (BPH). Yet the large, high-quality trials paint a different picture.

The STEP trial (2006) and CAMUS trials (2011) have not found significant benefit for saw palmetto in treating BPH. Saw palmetto extract does not affect serum prostate-specific antigen (PSA) more than placebo, even at relatively high doses. Standard dosing is 320 mg standardized extract.

A 2023 review of 27 studies on saw palmetto in men with BPH concluded that saw palmetto, when administered alone, provides little or no benefit for BPH symptoms. The authors stated plainly: "We know enough to conclude that saw palmetto is probably not helpful for this purpose."

So why does saw palmetto persist despite negative evidence? Several factors contribute: historical use and traditional medicine reputation, prescription status in some European countries creating perception of legitimacy, early positive studies (publication bias, smaller studies), consumer demand and market momentum, and a relatively safe profile with few side effects.

Beta-sitosterol shows more favorable evidence. Multiple studies show beta-sitosterol significantly improves lower urinary tract symptoms associated with BPH, though effectiveness is generally less than pharmaceutical-grade alpha-adrenergic receptor antagonists or 5α-reductase inhibitors. Clinical studies consistently show beta-sitosterol at 60-130 mg per day significantly improves urinary symptom scores and peak urine flow rates in men with BPH.

Beta-sitosterol-enriched saw palmetto formulations like VISPO (containing more than 3% β-sitosterol and 85% total fatty acids) have shown they can improve or reduce severity of mild urinary symptoms in healthy participants and those with BPH. A 2024 double-blind, placebo-controlled study found phytosterol-enriched saw palmetto oil improved BPH symptoms.

The key limitation: beta-sitosterol trials often report symptom and flow improvements but no meaningful reduction in prostate size and limited long-term data.

Other prostate health ingredients show varying degrees of evidence:

Pygeum (Prunus africana): Multiple analyses concluded pygeum provides statistically significant improvement in urinary symptoms, especially reducing nighttime urination. Standard dose is 50-100 mg taken twice daily for 1-3 months.

Stinging nettle root (Urtica dioica): A randomized double-blind study of 100 patients with BPH showed stinging nettle root reduced clinical symptoms. It works by binding to sex hormone-binding globulin (SHBG), influencing prostate growth, acting as an anti-inflammatory agent, and helping relax smooth muscle tissue at the neck of the bladder. Dosing ranges from 300-600 mg of dried native nettle extracts.

Lycopene: Evidence is mixed. Dosing range is 15-30 mg daily. A pooled analysis of 6 studies showed no significant differences in PSA levels in subjects treated with lycopene or tomato extract compared to control. However, one study with 15 mg per day of lycopene for 6 months among 37 men with BPH showed a small (11.3%) but statistically significant decrease in serum PSA. More consistent clinical trials with larger sample sizes are needed.

The evidence is strongest for beta-sitosterol (symptom improvement, flow rates), followed by pygeum (nocturia reduction) and stinging nettle root (symptom reduction). Lycopene has mixed evidence with small effect sizes. These ingredients work best for symptomatic relief rather than addressing underlying prostate pathology. Standard saw palmetto extracts have weak evidence for BPH symptom relief based on large, high-quality trials.

The disconnect between evidence-based health needs and marketing priorities becomes most apparent when examining the supplements that could prevent the leading causes of death in men.

Cardiovascular disease and cancer are the top two leading causes of death. Cardiovascular disease remains the leading cause of mortality in the United States. Poor diet has surpassed smoking as the leading risk factor for death. Yet the supplements that address these risks (omega-3s, vitamin D, magnesium, fiber) are overshadowed by marketing for testosterone boosters and performance enhancers.

Omega-3 Fatty Acids: Cardiovascular Protection

The largest randomized, placebo-controlled clinical trial investigating cardiovascular effects of marine omega-3s (the 2019 VITAL trial) enrolled nearly 26,000 U.S. adults aged 50 and older without history of heart disease, stroke, or cancer and followed them for five years.

Overall findings showed no reduction in cardiovascular disease from omega-3 fatty acid supplementation. However, subgroup analysis revealed important benefits: researchers saw a 44% reduction in heart attacks in people with two or more heart disease risk factors and a 77% reduction in African American participants.

For cancer, omega-3 fatty acid supplementation had no effect on cancer incidence, nonvascular death, or total mortality compared to placebo. However, persons using fish oil supplements for 4+ days per week for 3+ years had about half the risk of colorectal cancer, with the association driven by colon cancer rather than rectal cancer and findings stronger for men than women.

The practical recommendation from healthcare providers: take a hard look at diet first and maximize nutrients from food. Focus on natural foods that are less processed. Omega-3-rich fish consumption remains the gold standard, but supplements may also provide benefit with no apparent harm.

Vitamin D: Common Deficiency, Nuanced Recommendations

The latest National Health and Nutrition Examination Survey (published 2022) found that 65.5% of Americans are deficient in vitamin D. Prevalence was lower in persons who were male (men have lower rates than women). CDC data from 2001-2006 showed season-adjusted prevalence at risk of deficiency at 1-8% in males, considerably lower than females.

The 2024 Endocrine Society guidelines suggest against empiric vitamin D supplementation for adults younger than 50 years and adults ages 50-74 years. Adults should follow the Recommended Daily Allowance of 600 IU (15 µg) daily for ages 50-70 and 800 IU (20 μg) daily for older than 70 years.

For adults over 75 years, empiric vitamin D supplementation is suggested.

The VITAL trial found that supplementation with vitamin D was not associated with a lower risk of cancer or cardiovascular disease. However, the recommendation from experts is that anyone around 50 or older should consider taking a vitamin D supplement, as people easily become low in or deficient in it.

Vitamin D deficiency is less common in men than women, but supplementation makes sense for men over 50, particularly those with limited sun exposure or darker skin tones. Despite negative findings in large trials, risk is minimal and cost is low. Vitamin D isn't marketed for "masculinity" or "performance," so it's overlooked in favor of exotic botanicals.

Magnesium: The Universally Underdosed Mineral

Analysis from NHANES 2013-2016 found that 48% of Americans of all ages ingest less magnesium from food and beverages than their respective Estimated Average Requirements. Adult men age 71 years and older and adolescent males are most likely to have low intakes.

NHANES 2017-March 2020 data showed average dietary magnesium intake of 339 mg per day for men ages 19 and older. 57% of men have inadequate dietary intakes (less than the EAR) of magnesium. The RDA for men ages 19-30 is 400 mg daily, and for ages 31+ is 420 mg daily.

Subclinical magnesium deficiency is a principal driver of cardiovascular disease and a public health crisis.

Magnesium supports over 300 bodily functions, including testosterone production. Deficiency is common among older men due to poor diet choices, depleted soil, and food processing methods. Effects of magnesium supplementation on testosterone levels have been observed in both athletes and sedentary subjects at rest and after exhaustion.

Magnesium helps regulate melatonin and GABA, promoting deeper, more restful sleep. It supports recovery, mood stability, and cognitive function. Emerging research shows taking magnesium at night may help increase testosterone levels, particularly when paired with deep, uninterrupted sleep.

For form selection:

Magnesium glycinate is often considered one of the best forms for supporting testosterone levels. It has good bioavailability, may help improve sleep quality (important for testosterone production), and is gentle on the digestive system. Best for sleep support, testosterone support, and muscle relaxation.

Magnesium citrate is one of the most popular types, easily absorbed by the body, with a mild laxative effect. Best for digestive support, general supplementation, and cost-effectiveness.

Magnesium L-threonate is easily absorbed and may be the most effective type for increasing magnesium concentrations in brain cells. Best for cognitive function, brain health, and neuroprotection.

Dosing range is 200-400 mg supplementation, with nighttime supplementation (especially glycinate) optimizing sleep quality and nocturnal testosterone production.

Magnesium deficiency is widespread in men (57% below EAR), yet it's rarely emphasized in men's health marketing. Magnesium supports testosterone production indirectly through sleep quality, stress reduction, and metabolic function. Glycinate is the preferred form for testosterone and sleep support.

Fiber: Colon Cancer Prevention

Strong evidence shows that dietary factors including whole grains and high-fiber diet can affect risk of colon cancer. High-fiber diet is associated with lower risk of all cancers, lower risk of cardiovascular and respiratory diseases, and reduction in all-cause mortality.

Comparing the highest quartile of fiber intake to the lowest, mortality rates (per 1000) show: all-cause mortality 6.82 vs. 12.61, cancer mortality 1.73 vs. 2.47, and CVD mortality 1.27 vs. 2.42.

Colon cancer is one of the leading cancers in men. Fiber intake is modifiable through diet and supplementation. Most men consume far below the recommended fiber intake of 25-38g daily.

Fiber supplements are cheap, effective, and have massive health impact. They're not marketed to men because they don't fit the "alpha male" narrative. No supplement brand wants to talk about bowel health and cancer prevention when they can sell "testosterone support" and "male vitality."

Creatine monohydrate is the most evidence-backed supplement for men across multiple health outcomes, yet it's rarely included in men's health formulations. The reasons are practical: the effective dose is 5 grams daily (too large for capsule-based products), cost per serving is higher than herbal extracts dosed in milligrams, and it's not marketed for "testosterone" or "virility."

Muscle Performance

Creatine is a well-established ergogenic aid that enhances resistance training adaptations. The combination of creatine supplementation and resistance training provides improvements in lean mass, regional (limb) muscle thickness, upper- and lower-body muscle strength, and functional ability. It may enhance power or speed bursts requiring short periods of anaerobic activity. Taking creatine by mouth improves rowing, jumping, and soccer performance.

Cognition and Brain Health

Creatine supplementation may increase brain creatine levels and improve measures of cognitive function (memory, processing speed, executive function) and sport skill execution. Effects appear stronger when the brain is stressed (sleep deprivation, mental fatigue, hypoxia). 5 of 6 studies (83.3%) reported a positive relationship between creatine and cognition in older adults, particularly in domains of memory and attention.

Bone Density

Creatine can increase the activity of osteoblasts (cells involved in bone formation) and reduce bone resorption (loss). When combined with resistance training, it can increase muscle-to-bone interaction. However, the majority of research suggests creatine is more "hype" than "hope" for improving bone mass in older adults. Creatine supplementation alone (with no exercise stimulus) fails to produce bone benefits in older adults.

Safety: Kidney Concerns Debunked

2024-2025 research consensus shows creatine supplementation is associated with a modest, transient increase in serum creatinine levels, likely due to metabolic turnover rather than renal impairment. No significant changes are observed in GFR (glomerular filtration rate), suggesting preserved kidney function.

Blood creatinine levels may rise as a result of chronic creatine supplementation (raises total body creatine), but this increase does not indicate compromised renal function. Studies consistently show no adverse effects on renal function in healthy individuals. Caution is advised for those with pre-existing kidney conditions and pregnant women (evidence lacking for these populations).

Despite a few case reports and animal studies suggesting creatine may impair kidney function, clinical trials with controlled designs do not support this claim. Most early reports rely on retrospective observational data from individuals with preexisting kidney conditions, who engaged in high-intensity exercise, and who abused other substances known to affect renal function.

Accumulating research shows creatine monohydrate, primarily when combined with exercise training, is safe and has beneficial effects on whole-body lean mass, regional muscle size, muscle strength, bone area and thickness, functional ability, glucose kinetics, cognition and memory. Creatine supplementation poses no adverse effect on kidney or liver function.

Dosing

Loading phase (optional): 20-25 g creatine (0.3 g/kg day) for 5-7 days, followed by 3-5 g per day thereafter as maintenance dose.

Standard dosing (recommended): 3-5 grams per day is the general recommendation. 5 grams is the most-studied dosage and linked with the benefits most people seek.

Form: Creatine monohydrate is the most commonly used and most studied form. Other forms (creatine ethyl ester) have not shown added benefits.

Why Men's Health Formulas Don't Include It

A 5-gram daily dose equals 5,000 mg. A typical capsule holds 500-1,000 mg. This would require 5-10 capsules daily just for creatine. The dosing volume makes it impractical for multi-ingredient capsule formulations. Most men's health supplements use capsules with herbal extracts dosed in milligrams. Adding an effective dose of creatine would require a separate powder or large number of capsules. It doesn't fit the "testosterone booster" marketing narrative. Creatine is marketed separately as a sports performance supplement.

Creatine is the most evidence-backed supplement for men across muscle, cognition, and aging-related outcomes. The 5-gram daily dose and bulk form factor make it unsuitable for most men's health capsule formulations, but it deserves a place in any serious men's health protocol. Safety concerns about kidney function have been thoroughly debunked by recent systematic reviews.

The men's health supplement industry has perfected a marketing formula that exploits male anxieties around sexual performance and virility, physical strength and muscle mass, aging and declining testosterone, and masculinity and social status.

Common marketing themes include "boost testosterone naturally," "reclaim your alpha male status," "support male vitality," "enhance performance," and "feel like you're 20 again."

The regulatory framework creates opportunities for aggressive marketing. DSHEA (Dietary Supplement Health and Education Act) allows structure/function claims if claims are substantiated, claims are truthful and not misleading, the manufacturer notifies FDA, and the product includes the disclaimer: "This statement has not been evaluated by FDA and product is not intended to diagnose, mitigate, treat, cure, or prevent disease."

Manufacturers may strategically choose to use structure/function claims rather than health claims to avoid premarket approval requirements and avoid the more rigorous standard associated with health claims.

The regulatory framework creates opportunities for aggressive marketing making structure/function claims ("supports male vitality," "promotes healthy circulation") without requiring the same evidence standards demanded of medical treatments. The result is a marketplace flooded with products making similar promises backed by varying levels of scientific support.

The FDA does not regulate these products, and there is not enough evidence to suggest that most are effective in increasing testosterone levels.

Contamination Issues

Recent FDA alerts highlight the contamination problem:

• Rhino 69 Gummy (December 2024): Contaminated with undeclared tadalafil
• Rhino 11 Gummy (December 2024): Contaminated with undeclared tadalafil
• Alpha Male Plus (2013): Contaminated with six different hidden PDE5 inhibitor analogs

The FDA maintains hundreds of warnings for sexual enhancement products containing undeclared prescription drugs or dangerous chemical analogs.

FTC's Updated Approach

The FTC issued new guidance in December 2022 that applies broadly to all health-related claims. As a general matter, substantiation of health-related benefits will need to be in the form of randomized, controlled human clinical trials to meet the competent and reliable scientific evidence standard. Research that has not been through a rigorous peer-review process will be subject to greater scrutiny.

The FTC applies the same substantiation standards to any health-related claim, regardless of whether FDA would consider it a health claim, structure/function claim, or drug claim.

The Evidence Gap

90% of "T booster" supplements claimed to boost testosterone. However, on PubMed, only 24.8% of supplements had data showing an increase in testosterone with supplementation, 10.1% had data showing a decrease in testosterone, and 18.3% had data showing no change in testosterone.

90% claim testosterone benefits, only 24.8% have data to support these claims, and 65% of products make claims with no supporting evidence.

The testosterone therapy market is valued at about $4 billion. Subscription-based TRT is a billion-dollar global market segment with projections for nearly 9% annual growth over the next decade. Prescriptions for testosterone therapy rose to 11 million in 2024, with the sharpest increase among those 35-44, expanding nearly 60% in the last decade.

Prescription testosterone replacement therapy is safe and can be effective for men diagnosed with consistently abnormal low testosterone production and associated symptoms. The FDA has only approved TRT forms (gels, pills, patches, injections) for men who have both low testosterone and an associated medical condition.

Supplements aren't the anti-aging cure-alls that they're marketed as. When patients cannot access standard care, they're more likely to use less well-studied options like DHEA, which are unregulated supplements.

In February 2025, the FDA removed cardiovascular risk warnings from testosterone product labels following the TRAVERSE trial, which found no increased risk of adverse cardiovascular outcomes in men using testosterone for hypogonadism.

An FDA panel in 2025 advocated for regulatory changes to make testosterone medications more widely accessible, including removing classification as controlled substances and changing product labels to expand eligibility. Testosterone is currently classified as a Schedule 3 drug by the Drug Enforcement Administration (DEA). Panelists argued the DEA should remove Schedule 3 designation because prescriptions for Schedule 3 drugs must be carefully tracked, which may make physicians hesitant to prescribe and some pharmacies may choose not to carry the drugs or limit their volume.

Panelists also argued that current warning labels and contraindications for those with prostate cancer or suspected prostate cancer are not supported by contemporary evidence and should be removed. However, package insert warnings note that TRT has been shown to decrease male fertility, increase hematocrit, induce hepatic dysfunction, and may promote sodium and water retention resulting in edema.

The regulatory restrictions on TRT create market opportunity for the supplement industry. Men seeking testosterone support but unable to access prescription TRT turn to supplements with minimal evidence. This creates a two-tier system: prescription TRT (effective, regulated, evidence-based) for diagnosed hypogonadism, and OTC supplements (variable efficacy, minimal regulation) for men seeking testosterone support without medical diagnosis.

There's a fundamental difference between prescription testosterone replacement therapy (effective for diagnosed hypogonadism) and OTC testosterone supplements (minimal evidence, exploitative marketing). Recent regulatory changes in 2025 may expand access to prescription TRT, which could reduce demand for ineffective supplements. However, the "lifestyle use" market (men seeking performance enhancement rather than treating a medical condition) will continue to drive supplement sales.

Strong Evidence:

• Ashwagandha (KSM-66):: 600mg daily. Testosterone via cortisol reduction. Effects become significant at 2-4 weeks, full benefits at 8-12 weeks.
• Tongkat Ali (Physta):: 200mg daily. Testosterone in aging men. Increases seen within 2 weeks.
• Zinc:: 15-30mg daily (citrate or glycinate). Only if deficient. Takes 4-6 months to restore levels.
• Creatine:: 5g daily. Muscle, cognition, performance. Loading phase shows effects in 5-7 days; maintenance takes 3-4 weeks.
• Magnesium glycinate:: 200-400mg. Sleep, testosterone support. Sleep improvements in 1-2 weeks.

Modest Evidence:

• Fenugreek:: 250-600mg. Small free testosterone effects. 8-12 weeks for effects.
• Beta-sitosterol:: 60-130mg. Prostate symptom relief. 1-3 months for symptom improvement.

Weak/No Evidence:

• D-aspartic acid:: Replication failure
• Tribulus terrestris:: 8/10 studies negative
• Saw palmetto (alone):: Large trials negative

What Men Actually Need (50+):

• Omega-3s:: Fish > supplements
• Vitamin D:: 600-800 IU
• Fiber:: 25-38g daily

Do testosterone boosters actually work?
90% of testosterone boosters claim to boost testosterone, but only 24.8% have data showing an increase. Most don't work in healthy men with normal baseline levels.

What's the best testosterone supplement?
Ashwagandha (KSM-66) at 600mg and Tongkat Ali (Physta) at 200mg have the strongest evidence, working through cortisol reduction and supporting natural production.

Is creatine safe for your kidneys?
Yes. 2024-2025 research shows creatine causes a modest increase in serum creatinine (due to metabolic turnover) but no change in GFR, indicating preserved kidney function.

Does zinc increase testosterone?
Only if you're deficient. Zinc deficiency can reduce testosterone by up to 75%, but supplementation in replete men provides no benefit.

How long does it take for ashwagandha to work?
Effects on testosterone and cortisol become significant at 2-4 weeks, with full benefits at 8-12 weeks.

We design men's health formulations based on clinical evidence.

An evidence-based approach means:

1. Honest Ingredient Selection

Only include ingredients with human clinical trial support. Prioritize ingredients with multiple positive studies and meta-analyses. Eliminate ingredients with negative evidence. We eliminated D-aspartic acid after analyzing replication failures. We use KSM-66, not generic ashwagandha, because it's the form with clinical backing.

2. Proper Dosing

Use clinically validated doses from human studies. Ashwagandha KSM-66 at 600 mg daily (not 100 mg "proprietary blend"). Zinc at 15-30 mg (not 50 mg overdose). We dose zinc at 15-30mg, not 50mg megadoses, because higher doses don't work better. Magnesium glycinate at 200-400 mg (not underdosed citrate). Be transparent about dosing challenges (creatine requires 5 g, not practical in capsules).

3. Evidence Dossiers That Substantiate Real Claims

Provide complete evidence dossiers with cited human clinical trials, mechanism of action explanations, appropriate context (e.g., "zinc only works if deficient"), and honest assessment of effect sizes. Enable brands to make substantiated claims that meet FTC standards.

4. Address What Men Actually Need

Cardiovascular support (omega-3s, magnesium), vitamin D for men over 50, fiber for colon cancer prevention, stress management (ashwagandha for cortisol reduction), sleep quality (magnesium glycinate), and muscle and cognitive support (creatine). These don't fit the "alpha male" narrative but address leading causes of male mortality.

The men's health supplement market is worth $75 billion because it's built on effective marketing. Effective marketing isn't the same as effective products.

The gap between what's marketed and what works creates an opportunity for brands willing to be honest. 55% of testosterone booster consumers now demand transparency through third-party testing and detailed ingredient sourcing. The FTC's 2022 guidance requires RCTs for health-related claims. Most brands making testosterone claims cannot substantiate them.

Evidence-based formulation is a competitive advantage in a market built on hype.

We provide evidence-based formulation science for supplement brands that want to do better than the industry standard. Our Formulation Audit ($500/SKU) identifies ingredients with no evidence, dosing issues, and regulatory risks. Our Standard License Pack ($7,500 for U.S./Canada market) or Global License Pack ($15,000 for international markets) delivers full formulation, evidence dossier, FDA/MHRA compliance, CMO-ready specs, and Trust Mark in 5-15 days. Brands own everything, with no manufacturing lock-in.